(Q43791588)

26 November 2017

title

Comparative pharmacokinetics and pharmacodynamics of amlodipine in hypertensive patients with and without type II diabetes mellitus (English)

1 reference

26 November 2017

0 references

1 reference

1 reference

Preston RA

1

1 reference

26 November 2017

Chung M

2

1 reference

26 November 2017

Gaffney M

3

1 reference

26 November 2017

Alonso A

4

1 reference

26 November 2017

Baltodano NM

5

1 reference

26 November 2017

Epstein M

6

1 reference

26 November 2017

language of work or name

1 reference

1 November 2001

1 reference

The Journal of Clinical Pharmacology

26 November 2017

published in

1 reference

26 November 2017

volume

41

1 reference

26 November 2017

issue

11

1 reference

26 November 2017

page(s)

1215-1224

1 reference

Effects of diabetes on cardiovascular drug metabolism. Emerging clinical implications

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012760

The effects of diabetes mellitus on pharmacokinetics and pharmacodynamics in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012760

The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012760

Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012760

Current strategies for retarding progression of renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012760

The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012760

Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012760

Antihypertensive and anti-albuminuric effects of losartan potassium and felodipine in Chinese elderly hypertensive patients with or without non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012760

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012760

Amlodipine. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012760

Nisoldipine coat-core. A review of its pharmacology and therapeutic efficacy in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012760

Clinical pharmacology of nisoldipine coat core

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012760

Multiple Dose Pharmacokinetics of Four Different Doses of Nisoldipine in Hypertensive Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012760

Grapefruit juice and drugs. How significant is the interaction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012760

Rapid gastric emptying of a solid pancake meal in type II diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012760

Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012760

Calcium antagonists and the diabetic patient: a response to recent controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012760

Report on a workshop to develop management recommendations for the prevention of progression in chronic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012760

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012760

ACE inhibitors as a shield against diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012760

Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012760

Pharmacokinetic-pharmacodynamic modelling as a tool to evaluate the clinical relevance of a drug-food interaction for a nisoldipine controlled-release dosage form

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012760

Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012760

Serum protein binding of phenytoin and valproic acid in insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012760

10.1177/00912700122012760

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference